Clinical Trial Update: Study of TRC105 + Paclitaxel/Carboplatin and Bevacizumab in Patients With NSCLC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating TRC105 in combination with paclitaxel/carboplatin and bevacizumab for non-small cell lung cancer has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)
• TRC105 (carotuximab)

Snippet

Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Non Small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-10-28